Welcome to our dedicated page for Medical Prop SEC filings (Ticker: MPW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Medical Properties Trust Inc. filings document a self-advised REIT that owns and finances net-leased hospital real estate. Recent Form 8-K reports furnish operating and financial results, supplemental information, capital-allocation actions, Regulation FD communications, and other events, including the completed NYSE ticker change to MPT and the registration of common stock on the exchange.
Proxy materials describe board matters, executive compensation, equity awards and related shareholder voting disclosures. The filing record also covers the company's Maryland corporate status, common-stock capital structure, governance framework and formal exhibits used to report results and other material events for its healthcare real estate portfolio.
Medical Properties Trust, Inc. reported results of its annual stockholder meeting held on May 28, 2026. As of the March 19, 2026 record date, 602,829,003 shares of common stock were outstanding and entitled to vote, and 468,686,557 shares were represented, establishing a quorum.
Stockholders elected nine directors to serve until the 2027 annual meeting or until their successors are elected and qualify. They also approved the ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, supported by 459,883,831 votes. In addition, stockholders approved on a non-binding, advisory basis the compensation of named executive officers and approved the Second Amended and Restated 2019 Equity Incentive Plan.
Medical Properties Trust, Inc. reported results of its annual stockholder meeting held on May 28, 2026. As of the March 19, 2026 record date, 602,829,003 shares of common stock were outstanding and entitled to vote, and 468,686,557 shares were represented, establishing a quorum.
Stockholders elected nine directors to serve until the 2027 annual meeting or until their successors are elected and qualify. They also approved the ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, supported by 459,883,831 votes. In addition, stockholders approved on a non-binding, advisory basis the compensation of named executive officers and approved the Second Amended and Restated 2019 Equity Incentive Plan.
Medical Properties Trust, Inc. reported a return to profitability in the first quarter of 2026. Net income attributable to common stockholders was $32.8 million, or $0.05 per share, compared with a net loss of $118.3 million, or $(0.20) per share, a year earlier.
Total revenues rose to $252.1 million from $223.8 million, while normalized funds from operations held steady at $82.2 million, or $0.14 per share. The REIT ended the quarter with approximately $14.8 billion in total assets, a portfolio of 378 properties and about 38,000 licensed beds across nine countries. Management highlighted ramping rent payments at transitioned hospitals and reiterated confidence in collecting at least $1 billion in annualized cash rent by year-end and in addressing upcoming debt maturities.
Medical Properties Trust, Inc. reported a return to profitability in the first quarter of 2026. Net income attributable to common stockholders was $32.8 million, or $0.05 per share, compared with a net loss of $118.3 million, or $(0.20) per share, a year earlier.
Total revenues rose to $252.1 million from $223.8 million, while normalized funds from operations held steady at $82.2 million, or $0.14 per share. The REIT ended the quarter with approximately $14.8 billion in total assets, a portfolio of 378 properties and about 38,000 licensed beds across nine countries. Management highlighted ramping rent payments at transitioned hospitals and reiterated confidence in collecting at least $1 billion in annualized cash rent by year-end and in addressing upcoming debt maturities.
Vanguard Portfolio Management reported beneficial ownership of 43,145,708 shares of Medical Properties Trust Inc common stock, representing 7.21% of the class. The filing shows sole voting power of 60,944 shares and sole dispositive power over 43,145,708 shares. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 04/29/2026.
Vanguard Portfolio Management reported beneficial ownership of 43,145,708 shares of Medical Properties Trust Inc common stock, representing 7.21% of the class. The filing shows sole voting power of 60,944 shares and sole dispositive power over 43,145,708 shares. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 04/29/2026.
Medical Properties Trust, Inc. is asking stockholders to vote at its 2026 annual meeting on four main items: electing nine directors, ratifying PricewaterhouseCoopers as auditor for 2026, approving executive pay on an advisory basis, and approving an amended 2019 equity incentive plan.
The company highlights 2025 performance, including a 33% total shareholder return, a $2.2 billion reduction in near-term debt maturities, higher rent coverage of 2.6x, and a projected ~$1.0 billion 2026 annual cash rent. Management emphasizes balance sheet improvement, portfolio strength, and cash flow growth.
The proxy details a pay-for-performance compensation program, with 54% of the CEO’s 2025 target pay performance-based, rigorous TSR and revenue growth hurdles, and 2025 CEO “Actual Realized Compensation” of $9.7 million versus a Summary Compensation Table total of $15.9 million. The board underscores governance practices such as majority voting, proxy access, a lead independent director, and strong ESG and corporate responsibility initiatives.
Medical Properties Trust, Inc. is asking stockholders to vote at its 2026 annual meeting on four main items: electing nine directors, ratifying PricewaterhouseCoopers as auditor for 2026, approving executive pay on an advisory basis, and approving an amended 2019 equity incentive plan.
The company highlights 2025 performance, including a 33% total shareholder return, a $2.2 billion reduction in near-term debt maturities, higher rent coverage of 2.6x, and a projected ~$1.0 billion 2026 annual cash rent. Management emphasizes balance sheet improvement, portfolio strength, and cash flow growth.
The proxy details a pay-for-performance compensation program, with 54% of the CEO’s 2025 target pay performance-based, rigorous TSR and revenue growth hurdles, and 2025 CEO “Actual Realized Compensation” of $9.7 million versus a Summary Compensation Table total of $15.9 million. The board underscores governance practices such as majority voting, proxy access, a lead independent director, and strong ESG and corporate responsibility initiatives.
MEDICAL PROPERTIES TRUST INC Chairman, President & CEO Edward K. Aldag Jr. reported a tax-related share disposition. On the vesting of restricted stock, 109,433 common shares were withheld at $4.67 per share to satisfy tax withholding obligations, which the filing states does not constitute a sale transaction. After this withholding, Aldag directly holds 6,795,208 common shares of the company.
MEDICAL PROPERTIES TRUST INC Chairman, President & CEO Edward K. Aldag Jr. reported a tax-related share disposition. On the vesting of restricted stock, 109,433 common shares were withheld at $4.67 per share to satisfy tax withholding obligations, which the filing states does not constitute a sale transaction. After this withholding, Aldag directly holds 6,795,208 common shares of the company.
MEDICAL PROPERTIES TRUST INC Executive Vice President & CFO R. Steven Hamner reported a routine tax-related share disposition. On the vesting of restricted stock, 48,548 common shares were withheld at $4.67 per share to cover tax withholding obligations, which the company notes does not constitute a sale transaction. After this withholding, Hamner directly holds 3,841,020 shares of common stock.
MEDICAL PROPERTIES TRUST INC Executive Vice President & CFO R. Steven Hamner reported a routine tax-related share disposition. On the vesting of restricted stock, 48,548 common shares were withheld at $4.67 per share to cover tax withholding obligations, which the company notes does not constitute a sale transaction. After this withholding, Hamner directly holds 3,841,020 shares of common stock.
MEDICAL PROPERTIES TRUST INC executive Larry H. Portal, SVP and Senior Advisor to the CEO, had 4,048 common shares withheld at $4.67 per share to cover tax obligations on vested restricted stock. After this non-market, tax-withholding disposition, he directly holds 579,076 shares of common stock.
MEDICAL PROPERTIES TRUST INC executive Larry H. Portal, SVP and Senior Advisor to the CEO, had 4,048 common shares withheld at $4.67 per share to cover tax obligations on vested restricted stock. After this non-market, tax-withholding disposition, he directly holds 579,076 shares of common stock.
MEDICAL PROPERTIES TRUST INC senior vice president of finance and treasurer Charles R. Lambert reported a routine share disposition related to tax withholding. On the vesting of restricted stock, 2,347 common shares valued at $4.67 per share were withheld to satisfy tax obligations, and were not sold on the open market. Following this transaction, Lambert directly holds 390,054 shares of common stock.
MEDICAL PROPERTIES TRUST INC senior vice president of finance and treasurer Charles R. Lambert reported a routine share disposition related to tax withholding. On the vesting of restricted stock, 2,347 common shares valued at $4.67 per share were withheld to satisfy tax obligations, and were not sold on the open market. Following this transaction, Lambert directly holds 390,054 shares of common stock.
MEDICAL PROPERTIES TRUST INC senior vice president of operations Rosa Handley reported a routine share withholding related to equity compensation. Upon vesting of restricted stock, 1,938 common shares were withheld at $4.67 per share to satisfy tax obligations, which the company notes does not constitute a sale transaction. After this tax-withholding disposition, Handley directly holds 450,836 common shares of Medical Properties Trust.
MEDICAL PROPERTIES TRUST INC senior vice president of operations Rosa Handley reported a routine share withholding related to equity compensation. Upon vesting of restricted stock, 1,938 common shares were withheld at $4.67 per share to satisfy tax obligations, which the company notes does not constitute a sale transaction. After this tax-withholding disposition, Handley directly holds 450,836 common shares of Medical Properties Trust.
MEDICAL PROPERTIES TRUST INC Senior VP, Controller & CAO James Kevin Hanna reported a routine tax-related share withholding. On vesting of restricted stock, 3,295 common shares were withheld at $4.67 per share to cover tax obligations, which the company notes does not constitute a sale. Following this withholding, Hanna directly holds 543,499 common shares of Medical Properties Trust.
MEDICAL PROPERTIES TRUST INC Senior VP, Controller & CAO James Kevin Hanna reported a routine tax-related share withholding. On vesting of restricted stock, 3,295 common shares were withheld at $4.67 per share to cover tax obligations, which the company notes does not constitute a sale. Following this withholding, Hanna directly holds 543,499 common shares of Medical Properties Trust.